AWMM
GBIO

Aegis Wealth Management (Maryland)’s Generation Bio GBIO Stock Holding History

Aegis Wealth Management (Maryland)’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,889
Closed -$36K – 124
2025
Q2 		$36K Hold
8,889
– – 0.02% 114
2025
Q1 		$36K Hold
8,889
– – 0.02% 119
2024
Q4 		$94.2K Buy
+8,889
New +$158K 0.06% 109

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Aegis Wealth Management (Maryland)'s GBIO Position: Q3 2025 in Review

Aegis Wealth Management (Maryland) sold out of Generation Bio (GBIO) in Q3 2025, closing a stake of 8,889 shares — an estimated $36K sold.

Aegis Wealth Management (Maryland) first reported a position in GBIO in Q4 2024 and held it in 3 quarters. The position peaked at $94.2K in Q4 2024. 41 funds tracked by Wall St. Rank hold GBIO as of Q3 2025.

  • Aegis Wealth Management (Maryland) reported no remaining Generation Bio position as of Q3 2025 after selling out during the quarter.
  • Aegis Wealth Management (Maryland) sold 8,889 Generation Bio shares in Q3 2025, an estimated $36K.
  • Aegis Wealth Management (Maryland) first reported a position in Generation Bio in Q4 2024 and held it in 3 quarters.
  • Aegis Wealth Management (Maryland)'s Generation Bio position peaked at $94.2K in Q4 2024.
  • 41 funds tracked by Wall St. Rank held Generation Bio as of Q3 2025.

Based on Aegis Wealth Management (Maryland)'s 13F filing for Q3 2025, filed 6 Nov 2025.